During the last session, Madrigal Pharmaceuticals Inc (NASDAQ:MDGL)’s traded shares were 0.86 million, with the beta value of the company hitting -0.42. At the end of the trading day, the stock’s price was $280.16, reflecting an intraday loss of -1.93% or -$5.5. The 52-week high for the MDGL share is $299.98, that puts it down -7.07 from that peak though still a striking 57.25% gain since the share price plummeted to a 52-week low of $119.76. The company’s market capitalization is $5.97B, and the average trade volume was 470.14K shares over the past three months.
Madrigal Pharmaceuticals Inc (NASDAQ:MDGL) trade information
Madrigal Pharmaceuticals Inc (MDGL) registered a -1.93% downside in the last session and has traded in the green over the past 5 sessions. The stock plummet -1.93% in intraday trading to $280.16, hitting a weekly high. The stock’s 5-day price performance is 0.62%, and it has moved by 25.91% in 30 days. Based on these gigs, the overall price performance for the year is 26.38%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Madrigal Pharmaceuticals Inc (MDGL) estimates and forecasts
Statistics show that Madrigal Pharmaceuticals Inc has underperformed its competitors in share price, compared to the industry in which it operates. Madrigal Pharmaceuticals Inc (MDGL) shares have gone up 18.34% during the last six months, with a year-to-date growth rate less than the industry average at -38.17% against 13.90.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -55.24%. While earnings are projected to return -42.92% in 2024, the next five years will return 0.00% per annum.
MDGL Dividends
Madrigal Pharmaceuticals Inc is due to release its next quarterly earnings in July. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
